Some of President-elect Trump’s proposed nominees for top health posts, including Robert F. Kennedy Jr., are at odds with the drug industry, setting the stage for tense battles over regulatory changes. https://t.co/nrnNsDdOdr
— The New York Times (@nytimes) November 28, 2024
Categories